Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

The Value of Admission Clinical Data for Diagnosing Heart Failure in Long-term Care.

Heckman GA, Foebel AD, Dubin JA, Ng J, Turpie ID, Hussack P, McKelvie RS.

Can Geriatr J. 2013 Dec 3;16(4):147-55. doi: 10.5770/cgj.16.70. eCollection 2013.

2.

Heart failure--related mortality and hospitalization in the year following admission to a long-term care facility: the geriatric outcomes and longitudinal decline in heart failure (GOLD-HF) study.

Foebel AD, Heckman GA, Ji K, Dubin JA, Turpie ID, Hussack P, McKelvie RS.

J Card Fail. 2013 Jul;19(7):468-77. doi: 10.1016/j.cardfail.2013.05.003.

PMID:
23834923
3.

Detection of COPD Exacerbations and compliance with patient-reported daily symptom diaries using a smart phone-based information system [corrected].

Johnston NW, Lambert K, Hussack P, de Verdier MG, Higenbottam T, Lewis J, Newbold P, Jenkins M, Norman GR, Coyle PV, McIvor RA.

Chest. 2013 Aug;144(2):507-514. doi: 10.1378/chest.12-2308. Erratum in: Chest. 2014 Apr;145(4):929.

PMID:
23519329
4.

The Christmas season as a risk factor for chronic obstructive pulmonary disease exacerbations.

Johnston NW, McIvor A, Lambert K, Greene JM, Hussack P, Gerhardsson de Verdier M, Higenbottam T, Lewis J, Newbold P, Herath A, Jenkins M.

Can Respir J. 2010 Nov-Dec;17(6):275-81.

5.

Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations.

Jayaram L, Pizzichini MM, Cook RJ, Boulet LP, Lemière C, Pizzichini E, Cartier A, Hussack P, Goldsmith CH, Laviolette M, Parameswaran K, Hargreave FE.

Eur Respir J. 2006 Mar;27(3):483-94.

6.

Sputum induction: effect of nebulizer output and inhalation time on cell counts and fluid-phase measures.

Belda J, Hussack P, Dolovich M, Efthimiadis A, Hargreave FE.

Clin Exp Allergy. 2001 Nov;31(11):1740-4.

PMID:
11696050
7.

Success and safety of sputum induction in the clinical setting.

Vlachos-Mayer H, Leigh R, Sharon RF, Hussack P, Hargreave FE.

Eur Respir J. 2000 Nov;16(5):997-1000.

8.

Clinical judgement of airway inflammation versus sputum cell counts in patients with asthma.

Parameswaran K, Pizzichini E, Pizzichini MM, Hussack P, Efthimiadis A, Hargreave FE.

Eur Respir J. 2000 Mar;15(3):486-90.

9.

Sputum in asthma: color versus cell counts.

Berlyne GS, Efthimiadis A, Hussack P, Groves D, Dolovich J, Hargreave FE.

J Allergy Clin Immunol. 2000 Jan;105(1 Pt 1):182-3. No abstract available.

PMID:
10629470
10.

Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study.

Pizzichini MM, Pizzichini E, Efthimiadis A, Chauhan AJ, Johnston SL, Hussack P, Mahony J, Dolovich J, Hargreave FE.

Am J Respir Crit Care Med. 1998 Oct;158(4):1178-84.

PMID:
9769279
11.

Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: a randomized, placebo controlled trial.

Turner MO, Johnston PR, Pizzichini E, Pizzichini MM, Hussack PA, Hargreave FE.

Can Respir J. 1998 Jul-Aug;5(4):261-8.

12.

Potential masking effects of salmeterol on airway inflammation in asthma.

Mcivor RA, Pizzichini E, Turner MO, Hussack P, Hargreave FE, Sears MR.

Am J Respir Crit Care Med. 1998 Sep;158(3):924-30.

PMID:
9731027
13.

Induced sputum, bronchoalveolar lavage and blood from mild asthmatics: inflammatory cells, lymphocyte subsets and soluble markers compared.

Pizzichini E, Pizzichini MM, Kidney JC, Efthimiadis A, Hussack P, Popov T, Cox G, Dolovich J, O'Byrne P, Hargreave FE.

Eur Respir J. 1998 Apr;11(4):828-34.

14.

Spontaneous and induced sputum to measure indices of airway inflammation in asthma.

Pizzichini MM, Popov TA, Efthimiadis A, Hussack P, Evans S, Pizzichini E, Dolovich J, Hargreave FE.

Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):866-9.

PMID:
8887576
15.

Exacerbations of asthma without sputum eosinophilia.

Turner MO, Hussack P, Sears MR, Dolovich J, Hargreave FE.

Thorax. 1995 Oct;50(10):1057-61.

Supplemental Content

Loading ...
Support Center